Clinical trial
Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma…
NCT00029224 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00029224 |
|---|---|
| Title | Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions |
| Official title | A Prospective, Multicenter, Open-label Clinical Evaluation of the Effect of IV Zoledronic Acid 4mg on PAIN, QUALITY OF LIFE and TIME IN INFUSION CHAIR in Breast Cancer, Multiple Myeloma, and Prostate Cancer Patients With Cancer-related Bone Lesions |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Breast Cancer, Multiple Myeloma, Prostate Cancer |
| Intervention type | Drug |
| Interventions | zoledronic acid |
| Enrollment | 500 |
| Start date | Oct 1, 2001 |
| Primary completion | Nov 1, 2002 |
| Completion | Nov 1, 2002 |
| First posted | Jan 10, 2002 |
| Last update posted | Feb 1, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: